Company · CIK 0001411158 · SIC 2834 — Pharmaceutical Preparations
Anacor Pharmaceuticals, Inc. · ANAC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2016 DForm 4 → | Jun 24, 3:36 pm EDT | Anders D HoveDirector | 33,886 | $99.25 | $3,363,186 | 0 | — | plan? |
| Jun 24, 2016 DForm 4 → | Jun 24, 3:04 pm EDT | Lucy ShapiroDirector | 794 | $99.25 | $78,805 | 0 | — | plan? |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:59 pm EDT | William Jl RieflinDirector | 89,853 | $99.25 | $8,917,910 | 0 | — | plan? |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:58 pm EDT | Mark LeschlyDirector | 794 | $99.25 | $78,805 | 0 | — | plan? |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:56 pm EDT | Keith R LeonardDirector | 794 | $99.25 | $78,805 | 0 | — | plan? |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:55 pm EDT | Wendall WierengaDirector | 794 | $99.25 | $78,805 | 0 | — | plan? |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:49 pm EDT | Lee ZaneSVP and Chief Medical Officer | 44,194 | $99.25 | $4,386,255 | 0 | — | plan? |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:44 pm EDT | Graeme BellExecutive VP and CFO | 10,488 | $99.25 | $1,040,934 | 0 | — | plan? |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:43 pm EDT | Paul L BernsPresident and CEO, Director | 231,311 | $99.25 | $22,957,617 | 0 | — | plan? |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:41 pm EDT | Ryan T SullivanEVP and General Counsel | 30,132 | $99.25 | $2,990,601 | 0 | — | plan? |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:32 pm EDT | Vincent P IppolitoEVP & Chief Commercial Officer | 68,985 | $99.25 | $6,846,761 | 0 | — | plan? |
| Jun 1, 2016 SForm 4 → | Jun 3, 9:00 pm EDT | Graeme BellExecutive VP and CFO | 751 | $99.28 | $74,559 | 10,255 | −6.82% | plan? |
| May 23, 2016 SForm 4 → | May 24, 9:04 pm EDT | Keith R LeonardDirector | 9,000 | $99.70 | $897,300 | 794 | −91.9% | plan? |
| May 23, 2016 MForm 4 → | May 24, 9:04 pm EDT | Keith R LeonardDirector | 9,000 | $14.22 | $127,980 | 9,794 | — | plan? |
| May 16, 2016 SForm 4 → | May 18, 5:44 pm EDT | Anders D HoveDirector | 353,881 | $99.59 | $35,241,706 | 0 | −100% | plan? |
| Apr 29, 2016 SForm 4 → | Apr 29, 9:00 pm EDT | Ryan T SullivanEVP and General Counsel | 3,125 | $66.33 | $207,281 | 30,132 | −9.40% | plan? |
| Apr 14, 2016 CForm 4 → | Apr 15, 9:14 pm EDT | Anders D HoveDirector | 257,647 | $31.05 | $7,999,939 | 353,881 | — | plan? |
| Apr 7, 2016 SForm 4 → | Apr 11, 4:33 pm EDT | Anders D HoveDirector | 229,301 | $71.10 | $16,303,945 | 96,234 | −70.4% | plan? |
| Mar 31, 2016 MForm 4 → | Apr 4, 8:00 pm EDT | William Jl RieflinDirector | 89,000 | $8.33 | $741,080 | 89,000 | — | plan? |
| Mar 22, 2016 SForm 4 → | Mar 22, 9:00 pm EDT | Paul L BernsPresident and CEO, Director | 37,500 | $60.31 | $2,261,615 | 230,311 | −14.0% | plan? |
| Mar 2, 2016 SForm 4 → | Mar 4, 9:00 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 9,000 | $63.86 | $574,753 | 67,985 | −11.7% | plan? |
| Feb 3, 2016 AForm 4 → | Feb 5, 7:06 pm EST | Lee ZaneSVP and Chief Medical Officer | 4,375 | — | — | 44,044 | — | plan? |
| Feb 3, 2016 AForm 4 → | Feb 5, 7:04 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 5,000 | — | — | 76,985 | — | plan? |
| Feb 3, 2016 AForm 4 → | Feb 5, 7:03 pm EST | Ryan T SullivanEVP and General Counsel | 6,250 | — | — | 33,257 | — | plan? |
| Feb 3, 2016 AForm 4 → | Feb 5, 7:01 pm EST | Paul L BernsPresident and CEO, Director | 14,584 | — | — | 267,811 | — | plan? |
| Feb 3, 2016 AForm 4 → | Feb 5, 7:00 pm EST | Graeme BellExecutive VP and CFO | 5,000 | — | — | 11,006 | — | plan? |
| Jan 22, 2016 MForm 4 → | Jan 25, 9:01 pm EST | Lee ZaneSVP and Chief Medical Officer | 11,800 | $7.55 | $89,090 | 39,081 | — | plan? |
| Jan 19, 2016 SForm 4 → | Jan 21, 9:00 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 20,000 | $95.41 | $1,908,204 | 70,985 | −22.0% | plan? |
| Jan 19, 2016 MForm 4 → | Jan 21, 9:00 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 20,000 | $19.96 | $399,200 | 90,985 | — | plan? |
| Jan 15, 2016 SForm 4 → | Jan 19, 9:00 pm EST | Lee ZaneSVP and Chief Medical Officer | 1,466 | $89.57 | $131,310 | 27,281 | −5.10% | plan? |
| Jan 4, 2016 SForm 4 → | Jan 5, 9:33 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 855 | $112.28 | $96,002 | 70,985 | −1.19% | plan? |
| Jan 4, 2016 SForm 4 → | Jan 5, 9:31 pm EST | Ryan T SullivanSr. VP and General Counsel | 733 | $111.78 | $81,935 | 27,007 | −2.64% | plan? |
| Jan 4, 2016 SForm 4 → | Jan 5, 9:30 pm EST | Paul L BernsPresident and CEO, Director | 2,533 | $112.35 | $284,582 | 252,227 | −0.99% | plan? |
| Dec 15, 2015 SForm 4 → | Dec 17, 9:01 pm EST | Lee ZaneSVP and Chief Medical Officer | 14,000 | $113.17 | $1,584,346 | 28,747 | −32.8% | plan? |
| Dec 15, 2015 MForm 4 → | Dec 17, 9:01 pm EST | Lee ZaneSVP and Chief Medical Officer | 14,000 | $5.59 | $78,260 | 42,747 | — | plan? |
| Dec 15, 2015 SForm 4 → | Dec 17, 5:13 pm EST | Anders D HoveDirector | 900,000 | $111.25 | $100,125,000 | 325,535 | −73.4% | plan? |
| Dec 11, 2015 SForm 4 → | Dec 15, 9:00 pm EST | Paul L BernsPresident and CEO, Director | 20,000 | $117.26 | $2,345,247 | 254,760 | −7.28% | plan? |
| Dec 11, 2015 MForm 4 → | Dec 15, 9:00 pm EST | Paul L BernsPresident and CEO, Director | 20,000 | $10.00 | $200,060 | 274,760 | — | plan? |
| Dec 11, 2015 SForm 4 → | Dec 15, 5:09 pm EST | Anders D HoveDirector | 40,000 | $117.36 | $4,694,400 | 33,886 | −54.1% | plan? |
| Dec 10, 2015 SForm 4 → | Dec 11, 7:02 pm EST | Ryan T SullivanSr. VP and General Counsel | 10,000 | $110.41 | $1,104,105 | 27,740 | −26.5% | plan? |
| Dec 10, 2015 MForm 4 → | Dec 11, 7:02 pm EST | Ryan T SullivanSr. VP and General Counsel | 10,000 | $15.30 | $153,000 | 37,740 | — | plan? |
| Dec 9, 2015 SForm 4 → | Dec 11, 7:00 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 20,000 | $107.90 | $2,158,091 | 71,840 | −21.8% | plan? |
| Dec 9, 2015 MForm 4 → | Dec 11, 7:00 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 20,000 | $19.96 | $399,200 | 91,840 | — | plan? |
| Nov 10, 2015 JForm 4 → | Nov 12, 4:59 pm EST | Anders D HoveDirector | 446,074 | — | — | 73,886 | — | plan? |
| Nov 10, 2015 SForm 4 → | Nov 12, 4:59 pm EST | Anders D HoveDirector | 100,295 | $103.60 | $10,390,562 | 1,598,517 | −5.90% | plan? |
| Nov 3, 2015 JForm 4/A → | Nov 12, 4:55 pm EST | Anders D HoveDirector | 1,772,687 | — | — | 1,698,812 | — | plan? |
| Nov 3, 2015 JForm 4 → | Nov 5, 5:59 pm EST | Anders D HoveDirector | 1,872,982 | — | — | 1,598,517 | — | plan? amended |
| Sep 15, 2015 SForm 4 → | Sep 17, 9:46 pm EDT | Paul L BernsPresident and CEO, Director | 20,000 | $139.83 | $2,796,528 | 254,760 | −7.28% | plan? |
| Sep 15, 2015 MForm 4 → | Sep 17, 9:46 pm EDT | Paul L BernsPresident and CEO, Director | 20,000 | $5.18 | $103,640 | 274,760 | — | plan? |
| Sep 15, 2015 SForm 4 → | Sep 17, 9:45 pm EDT | Lee ZaneSVP and Chief Medical Officer | 14,000 | $139.84 | $1,957,700 | 28,744 | −32.8% | plan? |
| Sep 15, 2015 MForm 4 → | Sep 17, 9:45 pm EDT | Lee ZaneSVP and Chief Medical Officer | 14,000 | $5.59 | $78,260 | 42,744 | — | plan? |
| Aug 13, 2015 SForm 4 → | Aug 17, 8:00 pm EDT | Paul L BernsPresident and CEO, Director | 20,000 | $138.69 | $2,773,878 | 254,760 | −7.28% | plan? |
| Aug 13, 2015 MForm 4 → | Aug 17, 8:00 pm EDT | Paul L BernsPresident and CEO, Director | 20,000 | $5.11 | $102,200 | 274,760 | — | plan? |
| Jun 15, 2015 SForm 4 → | Jun 17, 6:56 pm EDT | Lee ZaneSVP and Chief Medical Officer | 12,000 | $69.05 | $828,590 | 28,156 | −29.9% | plan? |
| Jun 15, 2015 MForm 4 → | Jun 17, 6:56 pm EDT | Lee ZaneSVP and Chief Medical Officer | 12,000 | $6.44 | $77,269 | 35,817 | — | plan? |
| Jun 9, 2015 AForm 4 → | Jun 11, 7:51 pm EDT | Wendall WierengaDirector | 794 | — | — | 794 | — | plan? |
| Jun 9, 2015 AForm 4 → | Jun 11, 7:50 pm EDT | Keith R LeonardDirector | 794 | — | — | 794 | — | plan? |
| Jun 9, 2015 AForm 4 → | Jun 11, 7:48 pm EDT | William Jl RieflinDirector | 853 | — | — | 853 | — | plan? |
| Jun 9, 2015 AForm 4 → | Jun 11, 7:46 pm EDT | Mark LeschlyDirector | 794 | — | — | 794 | — | plan? |
| Jun 9, 2015 AForm 4 → | Jun 11, 7:45 pm EDT | Lucy ShapiroDirector | 794 | — | — | 794 | — | plan? |
| Jun 9, 2015 AForm 4 → | Jun 11, 1:56 pm EDT | Anders D HoveDirector | 794 | — | — | 794 | — | plan? |
| Jun 1, 2015 AForm 4 → | Jun 3, 7:35 pm EDT | Graeme BellExecutive VP and CFO | 6,006 | — | — | 6,006 | — | plan? |
| Jun 1, 2015 SForm 4 → | Jun 2, 8:00 pm EDT | Kirk R MaplesSVP, Program Management | 600 | $70.31 | $42,188 | 7,220 | −7.67% | plan? |
| May 15, 2015 SForm 4 → | May 15, 8:18 pm EDT | Jacob j PlattnerSenior VP, Research | 8,920 | $63.73 | $568,472 | 17,840 | −33.3% | plan? |
| May 12, 2015 SForm 4 → | May 14, 9:12 pm EDT | Kirk R MaplesSVP, Program Management | 6,060 | $61.07 | $370,087 | 7,820 | −43.7% | plan? |
| May 12, 2015 MForm 4 → | May 14, 9:12 pm EDT | Kirk R MaplesSVP, Program Management | 6,060 | $6.92 | $41,935 | 13,880 | — | plan? |
| May 12, 2015 SForm 4 → | May 14, 9:11 pm EDT | Carmen R RodriguezSnr VP Reg Afrs & Qual. Assur. | 61,942 | $62.73 | $3,885,323 | 7,020 | −89.8% | plan? |
| May 12, 2015 MForm 4 → | May 14, 9:11 pm EDT | Carmen R RodriguezSnr VP Reg Afrs & Qual. Assur. | 55,942 | $10.58 | $591,636 | 24,407 | — | plan? |
| May 1, 2015 SForm 4 → | May 1, 7:25 pm EDT | Kirk R MaplesSVP, Program Management | 600 | $53.95 | $32,370 | 7,820 | −7.13% | plan? |
| Apr 29, 2015 SForm 4 → | May 1, 5:01 pm EDT | Ryan T SullivanSr. VP and General Counsel | 3,125 | $53.61 | $167,531 | 27,740 | −10.1% | plan? |
| Apr 24, 2015 SForm 4 → | Apr 28, 8:37 pm EDT | Paul L BernsPresident and CEO, Director | 50,000 | $63.64 | $3,181,820 | 253,760 | −16.5% | plan? |
| Apr 15, 2015 SForm 4 → | Apr 17, 4:06 pm EDT | Jacob j PlattnerSenior VP, Research | 8,920 | $62.81 | $560,265 | 26,760 | −25.0% | plan? |
| Apr 1, 2015 SForm 4 → | Apr 3, 4:07 pm EDT | Kirk R MaplesSVP, Program Management | 600 | $57.02 | $34,209 | 8,420 | −6.65% | plan? |
| Mar 23, 2015 PForm 4 → | Mar 23, 6:55 pm EDT | Geoffrey M. ParkerExecutive Vice President & CFO | 3,000 | $52.43 | $157,304 | 173,000 | +1.76% | plan? |
| Mar 20, 2015 GForm 4 → | Apr 28, 8:37 pm EDT | Paul L BernsPresident and CEO, Director | 5,000 | — | — | 303,760 | — | plan? late |
| Mar 19, 2015 SForm 4 → | Mar 23, 6:53 pm EDT | Paul L BernsPresident and CEO, Director | 37,500 | $56.07 | $2,102,644 | 308,760 | −10.8% | plan? |
| Mar 16, 2015 SForm 4 → | Mar 18, 7:35 pm EDT | Jacob j PlattnerSenior VP, Research | 8,920 | $55.60 | $495,952 | 35,680 | −20.0% | plan? |
| Mar 16, 2015 SForm 4 → | Mar 18, 7:33 pm EDT | Lee ZaneSVP and Chief Medical Officer | 12,000 | $56.44 | $677,225 | 28,156 | −29.9% | plan? |
| Mar 16, 2015 MForm 4 → | Mar 18, 7:33 pm EDT | Lee ZaneSVP and Chief Medical Officer | 12,000 | $6.92 | $83,040 | 40,156 | — | plan? |
| Mar 4, 2015 SForm 4 → | Mar 4, 7:22 pm EST | Sanjay ChandaSVP, Drug Development | 5,000 | $45.00 | $225,000 | 29,087 | −14.7% | plan? |
| Mar 4, 2015 MForm 4 → | Mar 4, 7:22 pm EST | Sanjay ChandaSVP, Drug Development | 5,000 | $7.25 | $36,264 | 29,135 | — | plan? |
| Mar 3, 2015 SForm 4 → | Mar 4, 7:20 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 9,000 | $43.88 | $394,937 | 70,603 | −11.3% | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 7:18 pm EST | Jacob j PlattnerSenior VP, Research | 6,875 | $44.02 | $302,656 | 44,600 | −13.4% | plan? |
| Mar 2, 2015 SForm 4 → | Mar 4, 7:17 pm EST | Kirk R MaplesSVP, Program Management | 600 | $43.95 | $26,369 | 9,020 | −6.24% | plan? |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:57 pm EST | Lee ZaneSVP and Chief Medical Officer | 5,865 | — | — | 28,156 | — | plan? |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:56 pm EST | Ryan T SullivanSr. VP and General Counsel | 5,865 | — | — | 30,865 | — | plan? |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:54 pm EST | Carmen R RodriguezSnr VP Reg Afrs & Qual. Assur. | 5,020 | — | — | 13,020 | — | plan? |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:53 pm EST | Jacob j PlattnerSenior VP, Research | 5,020 | — | — | 5,020 | — | plan? |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:52 pm EST | Kirk R MaplesSVP, Program Management | 5,020 | — | — | 9,620 | — | plan? |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:51 pm EST | Sanjay ChandaSVP, Drug Development | 5,020 | — | — | 29,087 | — | plan? |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:50 pm EST | Geoffrey M. ParkerExecutive Vice President & CFO | 6,840 | — | — | 94,840 | — | plan? |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:49 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 6,840 | — | — | 79,603 | — | plan? |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:48 pm EST | Paul L BernsPresident and CEO, Director | 20,260 | — | — | 346,260 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 4:10 pm EST | Kirk R MaplesSVP, Program Management | 600 | $37.41 | $22,448 | 4,600 | −11.5% | plan? |
| Feb 2, 2015 SForm 4 → | Feb 4, 4:08 pm EST | Jacob j PlattnerSenior VP, Research | 6,875 | $37.35 | $256,781 | 51,475 | −11.8% | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 4:27 pm EST | Jacob j PlattnerSenior VP, Research | 6,875 | $32.09 | $220,619 | 58,350 | −10.5% | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 4:25 pm EST | Kirk R MaplesSVP, Program Management | 600 | $31.96 | $19,174 | 4,200 | −12.5% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2016 DForm 4 → | Jun 24, 3:36 pm EDT | Anders D HoveDirector | 91,596 | — | — | 0 | — | |
| Jun 24, 2016 DForm 4 → | Jun 24, 3:04 pm EDT | Lucy ShapiroDirector | 12,409 | — | — | 0 | — | |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:59 pm EDT | William Jl RieflinDirector | 4,403 | — | — | 0 | — | |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:58 pm EDT | Mark LeschlyDirector | 103,096 | — | — | 0 | — | |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:56 pm EDT | Keith R LeonardDirector | 22,096 | — | — | 0 | — | |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:55 pm EDT | Wendall WierengaDirector | 31,096 | — | — | 0 | — | |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:49 pm EDT | Lee ZaneSVP and Chief Medical Officer | 291,927 | — | — | 0 | — | |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:44 pm EDT | Graeme BellExecutive VP and CFO | 71,104 | — | — | 0 | — | |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:43 pm EDT | Paul L BernsPresident and CEO, Director | 579,362 | — | — | 0 | — | |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:41 pm EDT | Ryan T SullivanEVP and General Counsel | 98,583 | — | — | 0 | — | |
| Jun 24, 2016 DForm 4 → | Jun 24, 2:32 pm EDT | Vincent P IppolitoEVP & Chief Commercial Officer | 126,629 | — | — | 0 | — | |
| May 23, 2016 MForm 4 → | May 24, 9:04 pm EDT | Keith R LeonardDirector | 9,000 | — | — | 18,000 | — | |
| Apr 14, 2016 CForm 4 → | Apr 15, 9:14 pm EDT | Anders D HoveDirector | — | — | — | — | — | |
| Mar 31, 2016 MForm 4 → | Apr 4, 8:00 pm EDT | William Jl RieflinDirector | 89,000 | — | — | 0 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 7:06 pm EST | Lee ZaneSVP and Chief Medical Officer | 26,511 | — | — | 4,375 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 7:04 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 30,299 | — | — | 5,000 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 7:03 pm EST | Ryan T SullivanEVP and General Counsel | 37,873 | — | — | 6,250 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 7:01 pm EST | Paul L BernsPresident and CEO, Director | 88,372 | — | — | 14,584 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 7:00 pm EST | Graeme BellExecutive VP and CFO | 30,299 | — | — | 5,000 | — | |
| Jan 22, 2016 MForm 4 → | Jan 25, 9:01 pm EST | Lee ZaneSVP and Chief Medical Officer | 11,800 | — | — | 0 | — | |
| Jan 19, 2016 MForm 4 → | Jan 21, 9:00 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 20,000 | — | — | 61,000 | — | |
| Dec 15, 2015 MForm 4 → | Dec 17, 9:01 pm EST | Lee ZaneSVP and Chief Medical Officer | 14,000 | — | — | 27,661 | — | |
| Dec 11, 2015 MForm 4 → | Dec 15, 9:00 pm EST | Paul L BernsPresident and CEO, Director | 20,000 | — | — | 294,000 | — | |
| Dec 10, 2015 MForm 4 → | Dec 11, 7:02 pm EST | Ryan T SullivanSr. VP and General Counsel | 10,000 | — | — | 30,000 | — | |
| Dec 9, 2015 MForm 4 → | Dec 11, 7:00 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 20,000 | — | — | 81,000 | — | |
| Sep 15, 2015 MForm 4 → | Sep 17, 9:46 pm EDT | Paul L BernsPresident and CEO, Director | 20,000 | — | — | 14,000 | — | |
| Sep 15, 2015 MForm 4 → | Sep 17, 9:45 pm EDT | Lee ZaneSVP and Chief Medical Officer | 14,000 | — | — | 41,661 | — | |
| Aug 13, 2015 MForm 4 → | Aug 17, 8:00 pm EDT | Paul L BernsPresident and CEO, Director | 20,000 | — | — | 4,000 | — | |
| Jun 15, 2015 MForm 4 → | Jun 17, 6:56 pm EDT | Lee ZaneSVP and Chief Medical Officer | 12,000 | — | — | 33,239 | — | |
| Jun 9, 2015 AForm 4 → | Jun 11, 7:51 pm EDT | Wendall WierengaDirector | 4,096 | — | — | 4,096 | — | |
| Jun 9, 2015 AForm 4 → | Jun 11, 7:50 pm EDT | Keith R LeonardDirector | 4,096 | — | — | 4,096 | — | |
| Jun 9, 2015 AForm 4 → | Jun 11, 7:48 pm EDT | William Jl RieflinDirector | 4,403 | — | — | 4,403 | — | |
| Jun 9, 2015 AForm 4 → | Jun 11, 7:46 pm EDT | Mark LeschlyDirector | 4,096 | — | — | 4,096 | — | |
| Jun 9, 2015 AForm 4 → | Jun 11, 7:45 pm EDT | Lucy ShapiroDirector | 4,096 | — | — | 4,096 | — | |
| Jun 9, 2015 AForm 4 → | Jun 11, 1:56 pm EDT | Anders D HoveDirector | 4,096 | — | — | 4,096 | — | |
| Jun 1, 2015 AForm 4 → | Jun 3, 7:35 pm EDT | Graeme BellExecutive VP and CFO | 40,805 | — | — | 4,004 | — | |
| May 12, 2015 MForm 4 → | May 14, 9:12 pm EDT | Kirk R MaplesSVP, Program Management | 6,060 | — | — | 12,148 | — | |
| May 12, 2015 MForm 4 → | May 14, 9:11 pm EDT | Carmen R RodriguezSnr VP Reg Afrs & Qual. Assur. | 55,942 | — | — | 18,613 | — | |
| Mar 16, 2015 MForm 4 → | Mar 18, 7:33 pm EDT | Lee ZaneSVP and Chief Medical Officer | 12,000 | $6.92 | $83,040 | 40,900 | — | |
| Mar 4, 2015 MForm 4 → | Mar 4, 7:22 pm EST | Sanjay ChandaSVP, Drug Development | 5,000 | $7.25 | $36,264 | 13,552 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:57 pm EST | Lee ZaneSVP and Chief Medical Officer | 30,710 | — | — | 6,350 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:56 pm EST | Ryan T SullivanSr. VP and General Counsel | 30,710 | — | — | 6,350 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:54 pm EST | Carmen R RodriguezSnr VP Reg Afrs & Qual. Assur. | 22,320 | — | — | 1,475 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:53 pm EST | Jacob j PlattnerSenior VP, Research | 22,320 | — | — | 1,475 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:52 pm EST | Kirk R MaplesSVP, Program Management | 22,320 | — | — | 1,475 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:51 pm EST | Sanjay ChandaSVP, Drug Development | 22,320 | — | — | 1,475 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:50 pm EST | Geoffrey M. ParkerExecutive Vice President & CFO | 35,330 | — | — | 6,930 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:49 pm EST | Vincent P IppolitoEVP & Chief Commercial Officer | 35,330 | — | — | 6,930 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 8:48 pm EST | Paul L BernsPresident and CEO, Director | 96,990 | — | — | 12,890 | — |